Michael Seckl

17PUBLICATIONS
96CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of diseaseModels of care and place of birthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 27, 2026
Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.

|May 06, 2026
Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

|May 13, 2025
Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)-European Society of Gynaecologic Oncology (ESGO)-Gynecologic Cancer InterGroup (GCIG)-International Society for the Study of Trophoblastic Diseases (ISSTD).

Christianne Lok, Nienke van Trommel, Elena Ioana Braicu

|May 01, 2025
Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study.

Brenna E Swift, Leonoor Coopmans, Kam Singh

|Oct 07, 2024
Recurrence and resistance risk factors in low- risk gestational trophoblastic neoplasia.

Mariza Branco-Silva, Izildinha Maestá, Neil Horowitz

|Jan 10, 2024
Effectiveness of adjuvant systemic therapy following complete cytoreductive surgery in patients with recurrent granulosa cell tumours of the ovary.

Harika Yumru Celiksoy, Catriona Dickie, Michael J Seckl

Pageof 3

Frequent Collaborators

6 joint publications

Olivier E Pardo

3 joint publications

Geoffrey J Maher

2 joint publications

R C Coombes

2 joint publications

P D Badman